Celldex Therapeutics | CLDX - Equity Capital And Reserves

Stock Price
31.86
Daily Change
-1.37 -4.12%
Monthly
8.07%
Yearly
52.95%
Q2 Forecast
32.58

Celldex Therapeutics reported $527.16M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Agenus USD -271.11M 3.03M Dec/2025
Amgen USD 8.66B 961M Dec/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Celldex Therapeutics USD 527.16M 71.2M Dec/2025
Glaxosmithkline GBP 22.06B 360M Dec/2025
Nektar Therapeutics USD 89.83M 4.75M Dec/2025
Northwest Biotherapeutics USD -108.65M 8.26M Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Rigel Pharmaceuticals USD 117.61M 35.67M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025